
Gilead signs royalty-free licensing agreements with three generic manufacturers to expand future access to its investigational antiviral obeldesivir.
March 27, 2017
The University of Dundee (UK) has been awarded almost £1 million ($1.56 m) to boost efforts to find new new antibiotics to tackle bacterial infections.
The competitive award from
The grant will be spent on converting existing and appropriately located space into a medicinal chemistry laboratory that, together with existing infrastructure, will create the Antibacterial Drug Discovery Accelerator.






